Cyclosporine and low-dose ketoconazole in renal transplant recipients: A single-center experience

Transplantation

Volumn 77, Issue 7, 2004, Pages 1038-1040

  Carbajal, Hector ^a   Soltero, Liliana ^b   Rodríguez Montalvo, Carlos ^b   Valdés Cepeda, Alejandro ^b  

^a ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^b Hospital San Jose Tec de Monterrey   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; KETOCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; COLITIS; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; FEMALE; FEVER; FLATULENCE; HUMAN; KIDNEY TRANSPLANTATION; LIBIDO DISORDER; LIVER TOXICITY; LOW DRUG DOSE; LYMPHOCYTOPENIA; MALAISE; MALE; PRIORITY JOURNAL; VOMITING;

ADULT; ANTIFUNGAL AGENTS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 1942420171     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000122343.51904.C3     Document Type: Article

References (15)

1. Gomez DY, Wacher VJ, Tomlanovich SJ, et al. The effects of ketoconazole on the intestinal metabolism and bio-availability of cyclosporine. Clin Pharmacol Ther 1995; 58: 15.
2. Lo A, Burckart GJ. P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 1999; 39: 995.
3. Soltero L, Carbajal H, Rodriguez-Montalvo C, et al. Coadministration of tacrolimus and ketoconazole in renal transplant recipients: Cost analysis and review of metabolic effects. Transplant Proc 2003; 34: 1319.
4. Floren LC, Christians U, Zimmerman JJ, et al. Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole. Am Soc Clin Pharmacol Ther 1999; 65: 159.
5. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000; 4: 73.
6. Glass A, Eil C. Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 1986; 63: 766.
7. Loose DS, Kan PB, Hirst MA. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest 1983; 71: 1495.
8. Kraemer FB, Pont A. Inhibition of cholesterol synthesis by ketoconazole. Am J Med 1986; 80: 616.
9. First MR, Schroeder TJ, Michael A, et al. Cyclosporine-ketoconazole interaction: Long-term follow-up and preliminary results of a randomized trial. Transplantation 1993; 55: 1000.
10. Sobh MA, Hamdy AF, El Agroudy AE, et al. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: Long-term follow-up and study of metabolic consequences. Am J Kidney Dis 2001; 37: 510.
11. Keogh A, Spratt P, McCosker C, et al. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 1995; 333: 628.
12. Butman SM, Wild JC, Nolan PE, et al. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991; 10: 351.
13. Moore LW, Alloway RR, Acchiardo SR, et al. Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole. Transplantation 1996; 61: 537.
14. Patton PR, Brunson ME, Pfaff WW, et al. A preliminary report of diltiazem and ketoconazole: Their cyclosporine-sparing effect and impact on transplant outcome. Transplantation 1994; 57: 889.
15. Zurcher RM, Frey BM, Frey FJ. Impact of ketoconazole on the metabolism of prednisolone. Clin Pharmacol Ther 1989; 45: 366.